Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus on SGLT 2 Inhibitor Therapy in Singapore
Clinical trial NCT02578563 · COMPLETED
Trial details
- NCT number
- NCT02578563
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-02-12
- Primary completion
- 2018-12-31
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.